Human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMC
Abstract Transfusion of donor-derived red blood cells (RBC) depends on donor availability. Alloimmunization can limit the availability of transfusion units, particularly for chronically transfused patients. In vitro cultured, customizable RBC (cRBC) would negate these concerns and provide infinite R...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-81341-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850202816669286400 |
|---|---|
| author | Marie-José A. G. Claessen Nurcan Yagci Gerard van Mierlo Marie José Kersten Marieke von Lindern Emile van den Akker |
| author_facet | Marie-José A. G. Claessen Nurcan Yagci Gerard van Mierlo Marie José Kersten Marieke von Lindern Emile van den Akker |
| author_sort | Marie-José A. G. Claessen |
| collection | DOAJ |
| description | Abstract Transfusion of donor-derived red blood cells (RBC) depends on donor availability. Alloimmunization can limit the availability of transfusion units, particularly for chronically transfused patients. In vitro cultured, customizable RBC (cRBC) would negate these concerns and provide infinite RBC products. Previously, we developed a defined medium based on good manufacturing practice (GMP) requirements. To optimize medium conditions with regards to reproducibility and cost effectiveness, we tested the requirement for plasma during the differentiation phase and the replacement of HSA by polyvinyl alcohol (PVA) during the expansion and differentiation phase. We show that 5% plasma is essential to enhance cell count, enucleation% and mostly stability of cRBC during the differentiation phase. During the expansion phase HSA could be replaced by PVA without compromising the expansion capacity. Substitution of HSA by PVA even increased the number of cells at the end of the expansion phase. During the differentiation phase PVA could also replace HSA, but only in the presence of plasma. Plasma is still essential to achieve an optimum yield of enucleated cRBC, likely by stabilizing enucleated cRBC. Substitution of HSA by PVA is a new advancement in the development of a, defined, cost-effective culture medium to culture cRBC for all. |
| format | Article |
| id | doaj-art-51d5bb2ca034406f9ab1af6ef3a0f971 |
| institution | OA Journals |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-51d5bb2ca034406f9ab1af6ef3a0f9712025-08-20T02:11:41ZengNature PortfolioScientific Reports2045-23222025-04-0115111410.1038/s41598-024-81341-xHuman serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMCMarie-José A. G. Claessen0Nurcan Yagci1Gerard van Mierlo2Marie José Kersten3Marieke von Lindern4Emile van den Akker5Department Research, Sanquin Blood SupplyDepartment Research, Sanquin Blood SupplyDepartment Research, Sanquin Blood SupplyDepartment of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of AmsterdamDepartment Research, Sanquin Blood SupplyDepartment Research, Sanquin Blood SupplyAbstract Transfusion of donor-derived red blood cells (RBC) depends on donor availability. Alloimmunization can limit the availability of transfusion units, particularly for chronically transfused patients. In vitro cultured, customizable RBC (cRBC) would negate these concerns and provide infinite RBC products. Previously, we developed a defined medium based on good manufacturing practice (GMP) requirements. To optimize medium conditions with regards to reproducibility and cost effectiveness, we tested the requirement for plasma during the differentiation phase and the replacement of HSA by polyvinyl alcohol (PVA) during the expansion and differentiation phase. We show that 5% plasma is essential to enhance cell count, enucleation% and mostly stability of cRBC during the differentiation phase. During the expansion phase HSA could be replaced by PVA without compromising the expansion capacity. Substitution of HSA by PVA even increased the number of cells at the end of the expansion phase. During the differentiation phase PVA could also replace HSA, but only in the presence of plasma. Plasma is still essential to achieve an optimum yield of enucleated cRBC, likely by stabilizing enucleated cRBC. Substitution of HSA by PVA is a new advancement in the development of a, defined, cost-effective culture medium to culture cRBC for all.https://doi.org/10.1038/s41598-024-81341-xcRBC—cultured red blood cellsExpansionDifferentiationPlasmaPVA—polyvinyl alcoholHAS—human serum albumin |
| spellingShingle | Marie-José A. G. Claessen Nurcan Yagci Gerard van Mierlo Marie José Kersten Marieke von Lindern Emile van den Akker Human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMC Scientific Reports cRBC—cultured red blood cells Expansion Differentiation Plasma PVA—polyvinyl alcohol HAS—human serum albumin |
| title | Human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMC |
| title_full | Human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMC |
| title_fullStr | Human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMC |
| title_full_unstemmed | Human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMC |
| title_short | Human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from PBMC |
| title_sort | human serum albumin or polyvinyl alcohol can only partially replace human plasma during in vitro red cell production from pbmc |
| topic | cRBC—cultured red blood cells Expansion Differentiation Plasma PVA—polyvinyl alcohol HAS—human serum albumin |
| url | https://doi.org/10.1038/s41598-024-81341-x |
| work_keys_str_mv | AT mariejoseagclaessen humanserumalbuminorpolyvinylalcoholcanonlypartiallyreplacehumanplasmaduringinvitroredcellproductionfrompbmc AT nurcanyagci humanserumalbuminorpolyvinylalcoholcanonlypartiallyreplacehumanplasmaduringinvitroredcellproductionfrompbmc AT gerardvanmierlo humanserumalbuminorpolyvinylalcoholcanonlypartiallyreplacehumanplasmaduringinvitroredcellproductionfrompbmc AT mariejosekersten humanserumalbuminorpolyvinylalcoholcanonlypartiallyreplacehumanplasmaduringinvitroredcellproductionfrompbmc AT mariekevonlindern humanserumalbuminorpolyvinylalcoholcanonlypartiallyreplacehumanplasmaduringinvitroredcellproductionfrompbmc AT emilevandenakker humanserumalbuminorpolyvinylalcoholcanonlypartiallyreplacehumanplasmaduringinvitroredcellproductionfrompbmc |